TP53 and hepatocellular carcinoma: Since the unavailability of p53 status data in our cohort A, to further investigate the role of URI-SCD1 in HCC patients with different p53 status, we employed a new HCC cohort enrolled by Gao et.al, which we named as “Fudan_HCC_cohort”45.